JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
165.30 USD   -1.10%
08/12Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science
PR
08/12J&J to end sales of baby powder with talc globally next year
AQ
08/12There are two ways to see inflation data
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:

- pharmaceutical products (55.5%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;

- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;

- products for consumption by the general public (15.6%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.

At the end of 2021, Johnson & Johnson has 85 manufacturing facilities located in the United States (26), North America (9), Europe (25), Africa and Asia/Pacific (25).

Net sales break down geographically as follows: the United States (50.3%), North America (6.1%), Europe (25.2%), Asia/Pacific and Africa (18.4%).

Number of employees : 141 700 people.
Sales per Business
20202021Delta
Pharmaceutical45 572.0055.2%52 080.0055.5% +14.28%
Medical Devices22 959.0027.8%27 060.0028.9% +17.86%
Consumer14 053.0017%14 635.0015.6% +4.14%
USD in Million
Sales per region
20202021Delta
United States43 133.0052.2%47 156.0050.3% +9.33%
Europe18 980.0023%23 594.0025.2% +24.31%
Asia-Pacific, Africa15 136.0018.3%17 275.0018.4% +14.13%
Western Hemisphere Excluding United States5 335.006.5%5 750.006.1% +7.78%
USD in Million
Managers
Name Title Age Since
Joaquin Duato Chief Executive Officer & Director 59 2022
Joseph Wolk Chief Financial Officer & Executive Vice President 54 2018
Matthew Stuckley Senior Financial Analyst-Janssen Commercial Pharm - 2010
Peter Shen Global Head-Research & Development - 2017
Mathai Mammen EVP-Pharmaceuticals, Research & Development 54 -
James Swanson Global Chief Information Officer & Executive VP - 2019
Dan Zelem Chief Technology Officer - -
Jessica Moore Vice President-Investor Relations - 2021
Matthew Orlando Secretary - -
Jennifer Taubert Chairman-North America Pharmaceuticals - 2012
Members of the board
Name Title Age Since
Alex Gorsky Executive Chairman 61 2022
Anne M. Mulcahy Lead Independent Director 68 2012
Ian Davis Independent Non-Executive Director 70 2010
A. Eugene Washington, Dr. Independent Director 70 2012
Mark B. McClellan, Dr. Independent Director 57 2013
D. Davis Independent Director 69 2014
Mary C. Beckerle, Dr. Independent Director 66 2015
Jennifer A. Doudna, Dr. Independent Director 57 2018
Marillyn Hewson Independent Director 67 2019
Hubert Joly Independent Director 61 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,119,990,895 2,626,800,300 84.2% 490,811,000 15.7% 84.2%
Shareholders
NameEquities%
The Vanguard Group, Inc. 227,918,775 8.66%
SSgA Funds Management, Inc. 142,227,213 5.41%
BlackRock Fund Advisors 57,809,495 2.20%
Geode Capital Management LLC 45,021,546 1.71%
Northern Trust Investments, Inc.(Investment Management) 34,054,749 1.29%
Wellington Management Co. LLP 32,772,594 1.25%
Capital Research & Management Co. 32,520,000 1.24%
State Farm Investment Management Corp. 31,675,492 1.20%
Massachusetts Financial Services Co. 26,557,299 1.01%
Norges Bank Investment Management 24,393,111 0.93%
Holdings
NameEquities%Valuation
ARGENX SE (ARGX) 1,766,899 3.30% 660,375,621 USD
IDORSIA LTD (IDIA) 9,581,882 5.41% 136,619,528 USD
BIOCARTIS GROUP NV (BCART) 5,481,128 9.52% 10,944,771 USD
MOLECULAR PARTNERS AG (MOLN) 817,397 2.51% 5,626,618 USD
MAUNA KEA TECHNOLOGIES (MKEA) 10,811,687 24.3% 5,538,503 USD
CRYO-CELL INTERNATIONAL, INC. (CCEL) 152,882 1.81% 902,004 USD
ALLIGATOR BIOSCIENCE AB (PUBL) (ATORX) 2,991,847 1.36% 425,082 USD
GRAIL, INC. 50,868,671 7.58% 509 USD
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey

Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JOHNSON & JOHNSON-3.37%434 603
ELI LILLY AND COMPANY11.53%292 730
PFIZER, INC.-15.14%281 235
ROCHE HOLDING AG-16.91%275 562
ABBVIE INC.5.32%252 131
NOVO NORDISK A/S4.76%240 550
MERCK & CO., INC.18.76%230 579
ASTRAZENECA PLC23.44%201 219
NOVARTIS AG-0.22%185 374
BRISTOL-MYERS SQUIBB COMPANY21.20%161 361
AMGEN INC.10.41%132 871
SANOFI-3.52%109 706
GSK PLC-11.78%71 163
BAYER AG15.21%54 546
DAIICHI SANKYO CO., LTD.25.71%52 755
CHUGAI PHARMACEUTICAL CO., LTD3.37%47 539
TAKEDA PHARMACEUTICAL COMPANY LIMITED21.07%43 952
JIANGSU HENGRUI MEDICINE CO., LTD.-26.17%35 420
ASTELLAS PHARMA INC.8.77%27 823
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-31.37%26 844
CATALENT, INC.-14.11%19 708